Neurological Institute Outcomes
Cleveland Clinic’s Lou Ruvo Center for Brain Health cares for patients with a variety of neurocognitive disorders, including mild cognitive impairment (MCI), Alzheimer disease (AD), Lewy body dementia (LBD), and frontotemporal dementia (FTD). Patients are evaluated for changes in cognition, as measured by the Montreal Cognitive Assessment (MoCA); depressive symptoms, as measured by the Patient Health Questionnaire (PHQ-9); health-related quality of life, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS-10®); and sleep quality, as measured by the Insomnia Severity Index (ISI).
Change in Depressive Symptoms in Patients With Cognitive Disorders (N = 139)
2018 – 2019
AD = Alzheimer disease, FTD = frontotemporal dementia, LBD = Lewy body dementia, MCI = mild cognitive impairment